Valtech’s valuation team has recently completed a valuation for an international pharmaceutical group for its investments in European countries. We are glad to be a trusted valuation firm for delivering valuation opinion to clients from the life sciences and health care industry.

We have facilitated our client to evaluate the risk-adjusted rewards on potential investment and the recoverability of acquired and established business with scale of hundreds of millions in EUR. Market and industry benchmarking studies have been conducted to derive and support our conclusions.

Pharmaceutial Business

We have worked with both the European and Asian hubs of the group and dealt with enquires from the respective regional audit teams of an international audit firm. We have created additional value to ensure consistent, effective and seamless communication between their regional leaderships on the subject issues.

Why Appoint Valtech as Valuation Adviser?

Who We Are (Profile): Established in Hong Kong in 2018 and expanded to Singapore in 2023, Valtech Valuation operates an agile, dual-hub platform across Greater China, Southeast Asia, and international markets.

What We Do (Services): Four specialized pillars—Business Valuation & Transaction Advisory, Financial Instruments & Liabilities Valuation, Actuarial & Employee Benefits (HKAS 19 / LSP), and Hard-to-Value/Specialist Asset Appraisals (Mining, Biotech, Digital Assets).

Why Us (Competitive Edge):

    • Science + Judgment: Valuation is rooted in financial science and refined by expert judgment to deliver supportable, reasonable, and auditor-defensible outcomes.

    • Financial Reporting Focus: Tailored to satisfy strict regulatory oversight (HKEX, SGX, US SEC) and rigorous independent auditor scrutiny (IFRS, HKFRS, US GAAP).

    • Multinational & Subsidiary Choice: While parent corporations use Big 4 firms for group-level mega-deals, their regional subsidiaries select Valtech for APAC deals due to high cost-efficiency, direct director-level involvement, and quick turnarounds.

    • Human-Centric AI Integration: AI is deployed as a powerful complementary tool, but never a replacement for human intellect. Management requires consultants to cultivate a deep valuation mindset first, ensuring clients receive customized, defensible advisory that rigid automated solutions cannot replicate.

Proof Points (Track Record): Advised over 200 publicly listed companies, ISO 9001 certified quality management since 2021, proprietary digital infrastructure (valuation.vip), and a leadership team holding top international credentials (CPA, CFA, FRM, MRICS, AICPA ABV, CVA (Singapore), and China Certified Public Valuer).